Today: 19 July 2026
Salesforce stock price slips after hours: $50B buyback, Agentforce AI and what Wall Street watches next

Salesforce stock price slips after hours: $50B buyback, Agentforce AI and what Wall Street watches next

NEW YORK, Feb 27, 2026, 18:12 ET — Trading activity continued after the bell.

  • Salesforce ended the session at $194.79, down $4.68, or 2.35%. Shares slipped roughly 0.1% further after hours.
  • Salesforce’s fiscal 2027 revenue guidance and how quickly it’s rolling out AI remain under investor scrutiny.
  • March 6 brings the U.S. jobs report—a critical moment for those making bets on rates and eyeing tech stock valuations.

Salesforce, Inc. settled at $194.79 on Friday, shedding $4.68, or 2.35%. The shares barely budged in after-hours trading, slipping just to $194.58.

Salesforce’s slide leaves it exposed, with investors sorting out what so-called “agentic” AI actually spells for large, subscription-driven software names. The company’s current outlay on AI is significant, but the Street expects something more: evidence it can drive demand on its own, not just by playing with the numbers.

Initial reaction from Wall Street is wary. Stifel dropped its target on the stock to $250 from $300 but maintained its Buy call. DA Davidson trimmed its target to $200, holding steady at Neutral, citing weakness in certain legacy areas of Salesforce’s business.

Salesforce is projecting fiscal 2027 revenue to come in between $45.80 billion and $46.20 billion, landing just under the LSEG consensus at the midpoint—$46.06 billion. “Salesforce needs to show it is continuing to translate early AI traction into broader enterprise adoption,” said Rebecca Wettemann, CEO at Valoir. Wettemann pointed to the need for customers to get AI agents out of the pilot phase and running at scale. Reuters

Salesforce’s latest filing put remaining performance obligation—revenue under contract but not yet recognized—up 14% to $72.4 billion. Revenue for the quarter climbed 12% to $11.2 billion. The company greenlit a fresh $50 billion share buyback and bumped its quarterly dividend to $0.44 a share. CEO Marc Benioff described the “agentic AI” initiative as “a tailwind.” SEC

Salesforce shares picked up roughly 4% Thursday after the company’s quarterly revenue topped expectations. But by Friday, the stock slipped, trimming those gains as the week wrapped up.

No lift from the tape. Software names fell, with investors questioning if AI-fueled cost reductions might eventually eat into seat-based licensing. The iShares Expanded Tech-Software Sector ETF ended down roughly 1%, MarketWatch reported.

Another round of the same debate is coming next week, with markets twitchy over potential winners and losers. “There continues to be this back and forth about who might be the victim and those that will actually emerge winners,” said Kristina Hooper, chief market strategist at Man Group. Reuters

For Salesforce, the trouble comes if clients keep cutting back on tech spending or hold off on big deployments, which would hitch growth to renewals even as AI investments drive up expenses. Buybacks help the per-share numbers in that case, but they won’t solve the demand problem.

Investors are looking ahead to March 6, when the Labor Department is set to publish February’s U.S. jobs report at 8:30 a.m. ET — a release with the potential to sway rate bets and, in turn, put pressure on high-multiple software shares.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Molina Healthcare: Market Sentiment Misses the Mark
    July 19, 2026, 6:19 AM EDT. The market's reading of Molina Healthcare's valuation appears mistaken, opening a window for investors. An independent finance expert, experienced in macroeconomic analysis, technical patterns, and momentum-driven trading, makes the case that shares are currently undervalued. The analyst's method prioritises capital protection and a favourable risk-reward profile, blending Growth At A Reasonable Price (GARP) with momentum strategies for a balanced investment framework. The article highlights Molina Healthcare's prospects with actionable, data-backed observations in a turbulent market, encouraging investors to reassess the cautious outlook now prevailing.
Apple stock slips after the bell as tech cools; Cook teases “big week” of launches
Previous Story

Apple stock slips after the bell as tech cools; Cook teases “big week” of launches

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears
Next Story

Eli Lilly stock snaps skid on orforglipron pill data as April FDA clock nears

Go toTop